One page, thousands of outlets. See who else covered it.
Chinese biotech Biokin said its EGFRxHER3 bispecific antibody-drug conjugate passed a late-stage China trial in a genetically-defined form of lung cancer, buoying optimism for a similar global study led by its partner Bristol Myers Squibb. ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON…
VANCOUVER, British Columbia, Aug. 19, 2026 (GLOBE NEWSWIRE) — Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is…
Doctors at Helen Joseph Hospital in Johannesburg allegedly warned patients to seek treatment elsewhere.
Joycelyn Amoako needs urgent surgery at Korle Bu Teaching Hospital.
KOTA BHARU, Aug 19 — A baby girl who tested positive for drugs after being born at Raja Perempuan Zainab II Hospit...
KOTA BHARU, Aug 19 — A baby girl who tested positive for drugs after being born at Raja Perempuan Zainab II Hospit...
